Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market
Holding ANTH?
Track your performance easily

Anthera Pharmaceuticals (ANTH) Financial Statements

233 Followers

Anthera Pharmaceuticals Financial Overview

Anthera Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Anthera Pharmaceuticals is scheduled to report earnings on March 5, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 18Dec 17Sep 17Jun 17Mar 17
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.48M$ -9.67M$ -4.70M$ 313.00K$ -11.81M
EBITDA$ -4.32M$ -9.64M--$ -11.77M
Net Income Common Stockholders$ -6.02M$ -11.28M$ -4.70M$ 313.00K$ -14.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.09M$ 2.20M$ 6.08M$ 11.15M$ 20.65M
Total Assets$ 8.81M$ 3.67M$ 8.37M$ 14.51M$ 23.59M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -8.09M$ -2.20M$ -6.08M$ -11.15M$ -20.65M
Total Liabilities$ 3.35M$ 9.17M$ 8.03M$ 9.95M$ 20.83M
Stockholders Equity$ 5.46M$ -5.50M$ 343.00K$ 4.56M$ 2.76M
Cash Flow-
Free Cash Flow$ -9.02M$ -6.26M--$ -14.33M
Operating Cash Flow$ -9.38M$ -6.26M$ -6.20M$ -10.11M$ -14.33M
Investing Cash Flow$ 358.00K----
Financing Cash Flow$ 14.91M$ 2.38M$ 1.12M$ 612.00K$ 14.14M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

Anthera Pharmaceuticals Debt to Assets

Anthera Pharmaceuticals Cash Flow

Anthera Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis